Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.87%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
設定
言語
日本
通貨
USD
テーマ
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
株式のランク #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
株価
$0.02243487
最終同期: 2025-06-04
時価総額
$650.09K
変化（1日）
0.39%
変化（1年）
0.00%
国
SE
取引 Lipidor AB (publ) (LIPI)

カテゴリー

Healthcare
Lipidor AB (publ)（LIPI）の利益
Dec 2024 時点の利益 TTM: $-1.25M
Lipidor AB (publ) の最新の財務報告によると、同社の現在の利益は $-1.25M です。2023 年には $-1.14M の利益を上げ、これは 2022 年の利益 $-3.97M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Lipidor AB (publ) の利益の推移（2016 〜 2026）
各年末の利益
年 利益 変化
2026 (TTM) $-1.25M 0.00%
2024 $-1.25M 9.96%
2023 $-1.14M -71.31%
2022 $-3.97M 68.68%
2021 $-2.35M 19.98%
2020 $-1.96M 32.57%
2019 $-1.48M 73.02%
2018 $-854.84K 129.77%
2017 $-372.04K -30.69%
2016 $-536.78K 0.00%
同業他社の利益
企業 利益 利益の差 国
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -2,683,842.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -2,012,923.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -695,033.61%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -1,708,738.18%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -475,265.55%
US